Trial

Evaluation of SQ109, High-dose Rifampicin, and Moxifloxacin in Adults With Smear-positive Pulmonary TB in a MAMS Design

Study Director
Start Date
4 / 2013
Trial Phase
Trial Status
all patients enrolled
Current Enrollment
Target Enrollment
365
Overview
Compound Associations